[go: up one dir, main page]

PE20011089A1 - Tioamidas de oxazolidinona con sustituyentes de piperazin-amida - Google Patents

Tioamidas de oxazolidinona con sustituyentes de piperazin-amida

Info

Publication number
PE20011089A1
PE20011089A1 PE2001000132A PE2001000132A PE20011089A1 PE 20011089 A1 PE20011089 A1 PE 20011089A1 PE 2001000132 A PE2001000132 A PE 2001000132A PE 2001000132 A PE2001000132 A PE 2001000132A PE 20011089 A1 PE20011089 A1 PE 20011089A1
Authority
PE
Peru
Prior art keywords
alkyl
piperazin
phenyl
thioamides
oxazolidinone
Prior art date
Application number
PE2001000132A
Other languages
English (en)
Inventor
Hester
Original Assignee
Pharmacia And Upjhon Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia And Upjhon Company filed Critical Pharmacia And Upjhon Company
Publication of PE20011089A1 publication Critical patent/PE20011089A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A TIOAMIDAS DE OXAZOLIDINONA CON SUBSTITUYENTES DE PIPERAZIN-AMIDA DE FORMULA I DONDE A ES EL GRUPO i, ii ENTRE OTROS; W ES NHC(=S)R1, -Y-het SIEMPRE QUE A ES UNA ESTRUCTURA iv, W NO ES -Y-HET; Y ES NH, O, S; R1 ES H, NH2, NH-ALQUILO C1-C4, ALQUENILO C1-C4, 0-ALQUILO C1-C4, ENTRE OTROS; R2 Y R3 SON H, F, Cl, ALQUILO C1-C2; R4 ES -C(=O)-CR5R6-O-R7, -C(=O)-CH2S(O)n-CH3, ENTRE OTROS; R5 ES H; R6 ES FENILO, BENCILO, CH2OH, CH2OCH3; R5 Y R6 SON CICLOALQUILO C3-C5; R7 ES H, CH3, ALCANOILO C1-C4. SON COMPUESTOS PREFERIDOS N{[5S)-3-(3-FLUORO-4-}4-[2-(METILSULFINIL)ACETIL]-1-PIPERAZINIL}FENIL)-2-OXO-1,3-OXAZOLIDIN-5-IL]METIL}PROPANTIOAMIDA, N{[5S)-3-(3-FLUORO-4-}4-[2-(METILSULFANIL)ACETIL]-1-PIPERAZINIL}FENIL)-2-OXO-1,3-OXAZOLIDIN-5-IL]METIL}PROPANTIOAMIDA, ENTRE OTROS. LOS COMPUESTOS DE FORMULA I TIENEN ACTIVIDAD ANTIBACTERIANA
PE2001000132A 2000-02-10 2001-02-07 Tioamidas de oxazolidinona con sustituyentes de piperazin-amida PE20011089A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18164000P 2000-02-10 2000-02-10

Publications (1)

Publication Number Publication Date
PE20011089A1 true PE20011089A1 (es) 2001-10-04

Family

ID=22665142

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000132A PE20011089A1 (es) 2000-02-10 2001-02-07 Tioamidas de oxazolidinona con sustituyentes de piperazin-amida

Country Status (17)

Country Link
US (1) US20010047004A1 (es)
EP (1) EP1263742B1 (es)
JP (1) JP2003522763A (es)
KR (1) KR20020072311A (es)
CN (1) CN1395569A (es)
AR (1) AR029226A1 (es)
AT (1) ATE302762T1 (es)
AU (1) AU2001234428A1 (es)
BR (1) BR0107645A (es)
CA (1) CA2395648A1 (es)
CO (1) CO5271737A1 (es)
DE (1) DE60112903T2 (es)
ES (1) ES2248284T3 (es)
MX (1) MXPA02007719A (es)
NZ (1) NZ520696A (es)
PE (1) PE20011089A1 (es)
WO (1) WO2001058885A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6465456B2 (en) * 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
ATE321024T1 (de) * 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
BR0308018A (pt) * 2002-02-28 2005-01-04 Astrazeneca Ab Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
AU2003207340A1 (en) 2002-02-28 2003-09-09 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
EA200401289A1 (ru) * 2002-04-01 2005-04-28 Кадила Хелзкэр Лимитед Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
EP1546140A2 (en) * 2002-07-11 2005-06-29 Wockhardt Limited Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
US7217726B2 (en) * 2002-08-22 2007-05-15 Orchid Chemicals & Pharmaceuticals Limited Antibacterial agents
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
AR042086A1 (es) 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
WO2005005398A2 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
US20070185132A1 (en) * 2003-07-02 2007-08-09 Yasumichi Fukuda Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo
WO2005085266A2 (en) 2004-02-27 2005-09-15 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
WO2007025089A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceutical, Inc. Triazole compounds and methods of making and using the same
WO2007025098A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
WO2008073444A2 (en) * 2006-12-12 2008-06-19 The Johns Hopkins University Phou (perf), a persistence switch involved in persister formation as a drug target for persister bacteria
AU2008258549B2 (en) 2007-06-08 2013-11-14 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
ES2483898T3 (es) 2007-06-08 2014-08-08 Janssen Pharmaceutica, N.V. Derivados de piperidina/piperazina
CN101678019B (zh) 2007-06-08 2016-03-30 詹森药业有限公司 哌啶/哌嗪衍生物
CA2692255A1 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use
ES2617619T3 (es) 2008-06-05 2017-06-19 Janssen Pharmaceutica, N.V. Combinaciones de fármacos que comprenden un inhibidor de DGAT y un agonista de PPAR
CN115466253B (zh) * 2021-06-16 2024-08-20 沈阳药科大学 含二硫代氨基甲酸酯结构的噁唑烷酮类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76701B (es) * 1981-09-08 1984-08-29 Lilly Co Eli
DE69829846T2 (de) * 1997-05-30 2006-02-23 Pharmacia & Upjohn Co. Llc, Kalamazoo Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
AU9001598A (en) * 1997-09-11 1999-03-29 Hokuriku Seiyaku Co. Ltd Thiourea derivatives
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
BR0010982A (pt) * 1999-05-27 2002-03-05 Upjohn Co Novas oxazolidinonas bicìclicas como agentes antibacterianos

Also Published As

Publication number Publication date
ES2248284T3 (es) 2006-03-16
AU2001234428A1 (en) 2001-08-20
EP1263742A1 (en) 2002-12-11
BR0107645A (pt) 2002-10-08
JP2003522763A (ja) 2003-07-29
NZ520696A (en) 2004-03-26
DE60112903T2 (de) 2006-06-14
EP1263742B1 (en) 2005-08-24
KR20020072311A (ko) 2002-09-14
DE60112903D1 (de) 2005-09-29
ATE302762T1 (de) 2005-09-15
CN1395569A (zh) 2003-02-05
AR029226A1 (es) 2003-06-18
WO2001058885A1 (en) 2001-08-16
MXPA02007719A (es) 2002-10-11
US20010047004A1 (en) 2001-11-29
CA2395648A1 (en) 2001-08-16
CO5271737A1 (es) 2003-04-30

Similar Documents

Publication Publication Date Title
PE20011089A1 (es) Tioamidas de oxazolidinona con sustituyentes de piperazin-amida
PE20010931A1 (es) Oxazolidinonas que tienen la funcion de una sulfoximina
PE20010964A1 (es) Derivados de tiazolilamida
PE20020354A1 (es) Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
PE20010482A1 (es) Derivados de 3-ureido-pirazol y procedimiento para su preparacion
PE20040590A1 (es) Composiciones de pirrolotriazina anilina como inhibidores de cinasa
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
TR200401772T4 (tr) hPPAR alfa aktivatörleri olarak ikame edilmiş oksazol ve tiyazol türevleri.
PE20020544A1 (es) Derivados de indolilmaleimida
HRP20070510T3 (hr) Derivati benzimidazola i njihova upotreba kao antagonista ii receptora
PE20020585A1 (es) Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona
EA200901659A1 (ru) Соединения пиперазина с гербицидным действием
SE7503519L (sv) Mikrobiocider.
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
AR073688A1 (es) Agonistas de receptores cb2, derivados de oxazoles y/o triazoles, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del dolor, enfermedades autoinmunes y alergicas, entre otras.
PE20010634A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
EA200200769A1 (ru) Ингибиторы гиразы и их применение
TR200400185T4 (tr) PDE 5 inhibitörleri olarak, 8-kuinolinkisantin ve 8-izokuinolinkisantin türevleri.
PE20599A1 (es) Pirazoles como inhibidores de fosfolipasa secretora no pancreatica humana a2
AR065863A1 (es) Derivados de imidazolidinona
HRP20080493T3 (hr) Supstituirani kinolinski derivati kao mitotski inhibitori kinezina
SE9703377D0 (sv) New compounds
ES8601146A1 (es) Procedimiento para preparar derivados azolicos
PE20010851A1 (es) Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
ES2178451T3 (es) Derivados de benzoxadiazoles, benzotiadiazoles, benzotriazoles y quinoxalinas.

Legal Events

Date Code Title Description
FC Refusal